CG MedTech is a Republic of Korea-based medical device manufacturer focused on the development and production of orthopaedic and spinal implants, trauma products, pain management devices, sports medicine solutions and biologics. The company operates across multiple healthcare sectors, combining medical device engineering with regenerative medicine technologies and human tissue-based products. Its business has expanded beyond traditional implant manufacturing to include biomaterials, tissue processing, digital healthcare technologies and contract development and manufacturing services.

The company has built an integrated value chain covering research and development, product design, manufacturing, quality management and regulatory support. CG MedTech has also invested in advanced manufacturing technologies, including 3D-printed patient-specific implants, bioabsorbable materials and human tissue processing capabilities. Through acquisitions and strategic expansion initiatives, the company has broadened its portfolio into dental implants, spinal endoscopy and regenerative medicine-based products.

Key Products and Services

• Orthopaedic implants and fixation systems
• Spinal fixation devices and spinal fusion technologies
• Patient-specific interbody fusion cages produced using 3D printing technology
• Trauma and fracture treatment devices
• Pain management products and minimally invasive treatment technologies
• Sports medicine products
• Biologics and regenerative medicine solutions
• Human tissue processing and extracellular matrix (ECM)-based products
• Dental implants, fixtures and abutment systems
• Spinal endoscopy systems and related surgical technologies
• Contract development and manufacturing (CDMO) services for medical devices and human tissue products
• Regulatory, quality management and supply chain support services

CG MedTech continues to expand its position in the medical technology sector through investments in regenerative medicine, human tissue products, advanced implant technologies and manufacturing infrastructure. With operations spanning orthopaedics, spine, dental, biologics and CDMO services, the company is focused on supporting healthcare providers and commercial partners through integrated development, manufacturing and commercialisation capabilities across domestic and international markets.